ALLO · Allogene Therapeutics, Inc. · Exempt Offerings
$0.84
+0.01 (+1.41%)
At close · Nov 13
Return incl. dividend (before tax)
Play latest call
Q2 2026 earnings call transcript
Market Cap
$290.58M
Shares
346.47M
Volume · Nov 13
11.66M
Avg daily vol (3M)
7.37M
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Private capital raises reported to the SEC on Form D under Regulation D, showing the offering size, amount sold, minimum investment and number of investors. Public operating companies rarely raise capital this way, so this page is often empty.
No Exempt Offerings
No Form D exempt-offering notices are available for this stock yet.
Key facts
CIK
1737287
CUSIP
019770106
13F (30d)
158 filings
136 filers
Visit website
Investor relations